Dvorkin-Gheva A - Search Results

1

Identification of Drug Candidates to Suppress Cigarette Smoke-induced Inflammation via Connectivity Map Analyses.

Vanderstocken G, Dvorkin-Gheva A, Shen P, Brandsma CA, Obeidat M, Bossé Y, Hassell JA, Stampfli MR. Vanderstocken G, et al. Am J Respir Cell Mol Biol. 2018 Jun;58(6):727-735. doi: 10.1165/rcmb.2017-0202OC. Am J Respir Cell Mol Biol. 2018. PMID: 29256623

2

Hormone receptor and ERBB2 status in gene expression profiles of human breast tumor samples.

Dvorkin-Gheva A, Hassell JA. Dvorkin-Gheva A, et al. PLoS One. 2011;6(10):e26023. doi: 10.1371/journal.pone.0026023. Epub 2011 Oct 13. PLoS One. 2011. PMID: 22022496 Free PMC article.

3

A gene signature for predicting outcome in patients with basal-like breast cancer.

Hallett RM, Dvorkin-Gheva A, Bane A, Hassell JA. Hallett RM, et al. Sci Rep. 2012;2:227. doi: 10.1038/srep00227. Epub 2012 Jan 17. Sci Rep. 2012. PMID: 22355741 Free PMC article.

4

Identification of a novel luminal molecular subtype of breast cancer.

Dvorkin-Gheva A, Hassell JA. Dvorkin-Gheva A, et al. PLoS One. 2014 Jul 30;9(7):e103514. doi: 10.1371/journal.pone.0103514. eCollection 2014. PLoS One. 2014. PMID: 25076125 Free PMC article.

5

Identification and evaluation of network modules for the prognosis of basal-like breast cancer.

Hallett RM, Cockburn JG, Li B, Dvorkin-Gheva A, Hassell JA, Bane A. Hallett RM, et al. Oncotarget. 2015 Jul 10;6(19):17713-24. doi: 10.18632/oncotarget.4034. Oncotarget. 2015. PMID: 25991675 Free PMC article.

6

Serotonin transporter antagonists target tumor-initiating cells in a transgenic mouse model of breast cancer.

Hallett RM, Girgis-Gabardo A, Gwynne WD, Giacomelli AO, Bisson JN, Jensen JE, Dvorkin-Gheva A, Hassell JA. Hallett RM, et al. Oncotarget. 2016 Aug 16;7(33):53137-53152. doi: 10.18632/oncotarget.10614. Oncotarget. 2016. PMID: 27447971 Free PMC article.

7

Total particulate matter concentration skews cigarette smoke's gene expression profile.

Dvorkin-Gheva A, Vanderstocken G, Yildirim AÖ, Brandsma CA, Obeidat M, Bossé Y, Hassell JA, Stampfli MR. Dvorkin-Gheva A, et al. ERJ Open Res. 2016 Nov 9;2(4):00029-2016. doi: 10.1183/23120541.00029-2016. eCollection 2016 Oct. ERJ Open Res. 2016. PMID: 27995131 Free PMC article.

8

Claudin-Low Breast Cancer; Clinical & Pathological Characteristics.

Dias K, Dvorkin-Gheva A, Hallett RM, Wu Y, Hassell J, Pond GR, Levine M, Whelan T, Bane AL. Dias K, et al. PLoS One. 2017 Jan 3;12(1):e0168669. doi: 10.1371/journal.pone.0168669. eCollection 2017. PLoS One. 2017. PMID: 28045912 Free PMC article.

9

Kaiso depletion attenuates the growth and survival of triple negative breast cancer cells.

Bassey-Archibong BI, Rayner LG, Hercules SM, Aarts CW, Dvorkin-Gheva A, Bramson JL, Hassell JA, Daniel JM. Bassey-Archibong BI, et al. Cell Death Dis. 2017 Mar 23;8(3):e2689. doi: 10.1038/cddis.2017.92. Cell Death Dis. 2017. PMID: 28333150 Free PMC article.

10

Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts.

Gwynne WD, Hallett RM, Girgis-Gabardo A, Bojovic B, Dvorkin-Gheva A, Aarts C, Dias K, Bane A, Hassell JA. Gwynne WD, et al. Oncotarget. 2017 May 9;8(19):32101-32116. doi: 10.18632/oncotarget.16646. Oncotarget. 2017. PMID: 28404880 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters